A Panel of Cultures of Cancer and Normal Lung Cells with a Characterized Expression of PD-L1 to Search and Development of the Target Modifiers of Immunotherapy
Background. The search for effective combinations of immune checkpoint inhibitors with common cytostatics, targeted cancer drugs and other treatments is a modern trend to improve the effectiveness of immunotherapy.Purpose. Development of a panel of lung cancer cell cultures and cells of normal lung ti...
Saved in:
Main Authors: | T. A. Bogush, A. N. Grishanina, A. M. Scherbakov, D. A. Khochenkov, R. Yu. Yunusova, S. A. Kalyuzhny, V. S. Kosorukov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2024-11-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/1158 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolism of tryptophan in non-small lung cancer patients with different effect of PD-1 / PD-L1 inhibitors immunotherapy
by: E. Yu. Zlatnik, et al.
Published: (2022-06-01) -
CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escape
by: Zeyang Yang, et al.
Published: (2025-07-01) -
Cadonilimab as second-line therapy in immunotherapy-resistant squamous NSCLC: a case report and review
by: Shuo Qiu, et al.
Published: (2025-07-01) -
Immunotherapy of cancer tumors with inhibition of PD-1 membrane protein and its ligands interaction
by: A. V. Chetveryakov, et al.
Published: (2021-10-01) -
The possibilities of combination immunotherapy with radiation therapy for the treatment of patients with inoperable locally advanced non-small cell lung cancer
by: E. I. Smolenov, et al.
Published: (2021-06-01)